Pulmicort Turbuhaler 100/200 Specific Clinical Experience Investigation for Long Term Use in Pediatrics.
Phase of Trial: Phase IV
Latest Information Update: 05 Oct 2015
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Acronyms PEACE-Peds
- Sponsors AstraZeneca
- 30 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 10 Sep 2015 Planned End Date changed from 1 Aug 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 10 Sep 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.